Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgit Fogal

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of Neurochemistry|March 5, 2008
Interleukin-1beta: a bridge between inflammation and excitotoxicity?Birgit Fogal, Sandra J Hewett
Journal of Neuroimmunology|March 8, 2005
Interleukin-1beta potentiates neuronal injury in a variety of injury models involving energy deprivationBirgit Fogal, James A Hewett, Sandra J Hewett
Plos One|June 10, 2010
Diazoxide promotes oligodendrocyte precursor cell proliferation and myelinationBirgit Fogal, Carolyn McClaskey, Sha Yan, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 21, 2007
System x(c)- activity and astrocytes are necessary for interleukin-1 beta-mediated hypoxic neuronal injuryBirgit Fogal, Jun Li, Doug Lobner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 16, 2011
Neutralizing IL-6 reduces human arterial allograft rejection by allowing emergence of CD161+ CD4+ regulatory T cellsBirgit Fogal, Tai Yi, Chen Wang, et al.
Advanced Drug Delivery Reviews|April 2, 2021
Immunocompetent cancer-on-chip models to assess immuno-oncology therapyTengku Ibrahim Maulana, Elena Kromidas, Lars Wallstabe, et al.
Frontiers in Immunology|January 26, 2026
Perspective of using <i>in vitro</i> models to understand immunotherapy-induced cytokine release syndromeEthan Perkins, Christopher Cooper, Emma Lund, et al.
Regulatory Toxicology and Pharmacology : RTP|November 21, 2020
Industry experiences with immune-mediated findings in biotherapeutic nonclinical toxicology studiesTimothy K MacLachlan, Sven Kronenberg, Nikki Marshall, et al.
Frontiers in Immunology|December 29, 2025
Deep learning-aided inter-species-comparison reveals shared and distinct molecular patterns in cynomolgus monkey and humans following non-specific T cell activationVincent D Friedrich, Kari Neier, Kristina Müller, et al.
Frontiers in Pharmacology|July 1, 2026
Filling the mechanistic and methodological gaps for predicting cytokine release syndrome in humansLaure-Alix Clerbaux, Miriam Alb, Birgit Fogal, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Neurochemistry|March 5, 2008
Interleukin-1beta: a bridge between inflammation and excitotoxicity?Birgit Fogal, Sandra J Hewett
Journal of Neuroimmunology|March 8, 2005
Interleukin-1beta potentiates neuronal injury in a variety of injury models involving energy deprivationBirgit Fogal, James A Hewett, Sandra J Hewett
Plos One|June 10, 2010
Diazoxide promotes oligodendrocyte precursor cell proliferation and myelinationBirgit Fogal, Carolyn McClaskey, Sha Yan, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 21, 2007
System x(c)- activity and astrocytes are necessary for interleukin-1 beta-mediated hypoxic neuronal injuryBirgit Fogal, Jun Li, Doug Lobner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 16, 2011
Neutralizing IL-6 reduces human arterial allograft rejection by allowing emergence of CD161+ CD4+ regulatory T cellsBirgit Fogal, Tai Yi, Chen Wang, et al.
Advanced Drug Delivery Reviews|April 2, 2021
Immunocompetent cancer-on-chip models to assess immuno-oncology therapyTengku Ibrahim Maulana, Elena Kromidas, Lars Wallstabe, et al.
Frontiers in Immunology|January 26, 2026
Perspective of using <i>in vitro</i> models to understand immunotherapy-induced cytokine release syndromeEthan Perkins, Christopher Cooper, Emma Lund, et al.
Regulatory Toxicology and Pharmacology : RTP|November 21, 2020
Industry experiences with immune-mediated findings in biotherapeutic nonclinical toxicology studiesTimothy K MacLachlan, Sven Kronenberg, Nikki Marshall, et al.
Frontiers in Immunology|December 29, 2025
Deep learning-aided inter-species-comparison reveals shared and distinct molecular patterns in cynomolgus monkey and humans following non-specific T cell activationVincent D Friedrich, Kari Neier, Kristina Müller, et al.
Frontiers in Pharmacology|July 1, 2026
Filling the mechanistic and methodological gaps for predicting cytokine release syndrome in humansLaure-Alix Clerbaux, Miriam Alb, Birgit Fogal, et al.
Pageof 2